About Marker Therapeutics
Investors/Media
SEC Filings
Filing date Form Description View
8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
ARS An annual report to security holders View HTML
DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DEFA14A Additional proxy soliciting materials - definitive View HTML
8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-K Annual report which provides a comprehensive overview of the company for the past year EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
PRE 14A A preliminary proxy statement providing notification matters to be brought to a vote EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
4 Statement of changes in beneficial ownership of securities View HTML
4 Statement of changes in beneficial ownership of securities View HTML

Data provided by Kaleidoscope.